Molecular epidemiology of RAS/RAF-mutant colorectal cancer metastases

被引：0
|
作者：
Atreya, Chloe Evelyn
Watters, James
Rowley, Steve
Lee, Joon Sang
Iartchouk, Oleg
Light, Madelyn
Warren, Robert S.
Venook, Alan Paul
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Sanofi Oncol, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.470
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
470
引用
收藏
页数：1
相关论文
共 50 条
  • [41] RalB GTPase: A potential novel target for RAS mutant colorectal cancer
    Khawaja, H.
    O'Reilly, P.
    McArt, D.
    Harrison, T.
    Johnston, P.
    Van Schaeybroeck, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [42] Prognosis of Japanese patients with detailed RAS/BRAF mutant colorectal cancer
    Ikoma, T.
    Satake, H.
    Kotaka, M.
    Matsumoto, T.
    Yasui, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S1279 - S1279
  • [43] Molecular changes in the EGFR pathway and RAS/RAF genes identify subtypes of metastatic and nonmetastatic colorectal cancer associated with different outcomes
    Bahnassy, Abeer A.
    Salem, Salem E.
    Hussein, Nehal
    Yousif, Hend F.
    Al-Desouky, Marwa Iman
    Zekri, Abdel-Rahman N.
    CANCER RESEARCH, 2015, 75
  • [44] Clinical value of bile for the detection of mutant K-ras from colorectal liver metastases
    De Kok, JB
    Swinkels, DW
    Ruers, TJM
    ANTICANCER RESEARCH, 2000, 20 (04) : 2469 - 2472
  • [45] Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer
    Raimondi, Cristina
    Nicolazzo, Chiara
    Belardinilli, Francesca
    Loreni, Flavia
    Gradilone, Angela
    Mahdavian, Yasaman
    Gelibter, Alain
    Giannini, Giuseppe
    Cortesi, Enrico
    Gazzaniga, Paola
    CANCERS, 2019, 11 (01):
  • [46] Probing synthetic lethal interactions with RAF inhibition in BRAF-mutant colorectal cancer
    Whittaker, Steven R.
    Luo, Flora
    Hsiao, Jessica
    Cowley, Glenn S.
    Root, David E.
    Garraway, Levi A.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (05)
  • [47] Chemotherapy-induced Reversion of Mutant RAS to Wild-type RAS in Metastatic Colorectal Cancer
    Sato, Sumito
    Mikayama, Y. O.
    Shiozawa, Manabu
    Nukada, Suguru
    Iguchi, Kenta
    Okamoto, Hironao
    Kohmura, Takashi
    Kazama, Keisuke
    Tanaka, Kuniya
    Oshima, Takashi
    Rino, Yasushi
    ANTICANCER RESEARCH, 2022, 42 (05) : 2625 - 2635
  • [48] About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients
    Gazzaniga, Paola
    Nicolazzo, Chiara
    Caponnetto, Salvatore
    Cortesi, Enrico
    JCO PRECISION ONCOLOGY, 2021, 5 : 389 - 390
  • [49] Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer
    Edoardo Isnaldi
    Anna Garuti
    Gabriella Cirmena
    Stefano Scabini
    Edoardo Rimini
    Lorenzo Ferrando
    Michela Lia
    Roberto Murialdo
    Lucia Tixi
    Enrico Carminati
    Andrea Panaro
    Maurizio Gallo
    Federica Grillo
    Luca Mastracci
    Lazzaro Repetto
    Roberto Fiocca
    Emanuele Romairone
    Gabriele Zoppoli
    Alberto Ballestrero
    Journal of Translational Medicine, 17
  • [50] Metastatic bulk to predict subclonal heterogeneity by ctDNA in RAS/RAF-wildtype colorectal cancer
    Kratz, Jeremy D.
    Lubner, Sam Joseph
    LoConte, Noelle K.
    Patel, Monica Arun
    Uboha, Nataliya Volodymyrivna
    Lesnik, Dyan M.
    Ahmed, Sara
    Kelley, Michael J.
    Lemmon, Kayla
    Bassetti, Michael Frederick
    Sanger, Cristina
    Deming, Dustin A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
12345